Skip to main content
. 2022 Dec 20;13:1050876. doi: 10.3389/fimmu.2022.1050876

Figure 2.

Figure 2

Correlation between Tumor Mutational Burdens and Standardized Incidence Ratios in RA patients taking CSDMARDs or bDMARDs. Data on the x and y axis are shown on a logarithmic scale.